ClinicalTrialsElig / Git / [c09aa8] /clusters/clustall/WBC.txt

Models:
joseph-gordon/
ClinicalTrialsElig
Downloads: 1
[c09aa8]: / clusters / clustall / WBC.txt
History
Download this file
617 lines (616 with data), 17.6 kB

Absolute neutrophil count >= 1,500/mm^3
130.0
Absolute neutrophil count >= 1,500/mm^3
110.0
Absolute neutrophil count: >= 750/mm^3
62.0
Absolute neutrophil count < 1.5 x 10^9/L
45.0
Absolute neutrophil count >= 1.5 x 10^9/L
72.0
Absolute neutrophil count >= 1,500/mm^3
52.0
Absolute neutrophil count >= 1 x 10^9/L
68.0
Neutrophil count >= 1.5 x 10^9/L
250.0
Absolute neutrophil count: >= 750/mm^3 within 90 days before enrollment
5058.0
Absolute neutrophil count >= 1,000/mm^3
40.0
Absolute neutrophil count: >= 1,500/mm^3
56.0
Absolute neutrophil count >= 1,500/mm^3
126.0
Absolute neutrophil count >= 1,500/microliters
37.0
Absolute neutrophil count >= 1,500/mm^3 within 4 weeks prior to randomization
345.0
Absolute neutrophil count >= 1,500/mm^3
36.0
Absolute neutrophil count >= 1,500/mm^3
24.0
Absolute neutrophil count >= 1.0 x 10^9/L
25.0
Absolute neutrophil count >= 1500 cells/mm^3
612.0
Absolute neutrophil count < 1.5 x 10^9/L
98.0
Absolute neutrophil count >= 1500/mcL
102.0
Absolute neutrophil count >= 1,500/mcL
276.0
Absolute neutrophil count >= 1,000/mcL assessed within seven (7) days prior to the start of therapy
30.0
Absolute neutrophil count >= 1,500/mcl
162.0
REGISTRATION #2 - PRIOR TO CONSOLIDATION CHEMOTHERAPY: Absolute neutrophil count >= 1,500 mcl
162.0
Absolute neutrophil count >= 1,500/mcL
40.0
Absolute neutrophil count >= 1,500/mcL
107.0
Obtained within 30 days of registration: Absolute neutrophil count >= 1,500/mcL
24.0
Absolute neutrophil count >= 1,500/mcL
55.0
Absolute neutrophil count >= 1,500/mcL
165.0
Absolute neutrophil count >= 1,500/mcL
42.0
Absolute neutrophil count >= 1,500/mcL
36.0
Absolute neutrophil count >= 1,500/mcL
140.0
Absolute neutrophil count >= 1,500/mcL
68.0
Absolute neutrophil count >= 1,500/mcL
42.0
Absolute neutrophil count >= 1,500/mcL
73.0
Absolute neutrophil count >= 1,500/mcL
80.0
Absolute neutrophil count >= 1,500/mcL
70.0
Absolute neutrophil count >= 1,500/mcL
72.0
TUMOR BIOPSY SEQUENCING: Absolute neutrophil count >= 1,000/uL (mcL)
700.0
TREATMENT: Absolute neutrophil count >= 1,000/uL (mcL)
700.0
Absolute lymphocytes count >= 500/mcL
12.0
Absolute neutrophil count >= 1,000/mcL (without hematopoietic growth factors)
12.0
Absolute neutrophil count >= 1,500/mcL
54.0
Absolute neutrophil count >= 1,200/mcL
32.0
Absolute neutrophil count >= 1,500/mcL
100.0
Absolute neutrophil count >= 1,500/mcL
24.0
Absolute neutrophil count >= 1,500/mcL
600.0
Absolute neutrophil count >= 1,500/mcL
35.0
Absolute neutrophil count >= 1,500/mcL
40.0
Absolute neutrophil count >= 1,500/mcL (patients may be treated with hematopoietic growth factors to achieve or maintain this level)
44.0
Absolute neutrophil count >= 1,500/mcL
57.0
Absolute neutrophil count >= 750 cells/mcL (0.75 x 10^9/L)
52.0
Absolute neutrophil count >= 1,500/mcL
90.0
Lymphocyte count > 1,000/mcL
90.0
Absolute neutrophil count >= 1,500/mcL
36.0
Absolute neutrophil count >= 1,500/mcL
23.0
Absolute neutrophil count >= 1,000/mcL
80.0
Absolute neutrophil count >= 1,200/mcL
135.0
Absolute neutrophil count >= 1,500/mcL
37.0
Absolute neutrophil count >= 1,500/mcL
66.0
Absolute neutrophil count >= 1,500/mcL
12.0
Absolute neutrophil count >= 1,500/mcL** Participants may be receiving growth factor support to meet these criteria
42.0
Absolute neutrophil count >= 1,500/mcL
209.0
Absolute neutrophil count >= 1,500/mcL
30.0
Absolute neutrophil count >= 1,500/mcL
75.0
Absolute neutrophil count >= 1,500/mcL
50.0
Absolute neutrophil count >= 1,500/mcL
30.0
Absolute neutrophil count >= 1,500/mcL
549.0
Absolute neutrophil count >= 1,500/mcL
680.0
Absolute neutrophil count >= 1,500/mcL
46.0
Absolute neutrophil count >= 1,500/mcL
45.0
Absolute neutrophil count >= 1,500/mcL
82.0
Absolute neutrophil count >= 1,500/mcL
126.0
Absolute neutrophil count >= 1,500/mcL
50.0
Absolute neutrophil count >= 1,500/mcL
46.0
Absolute neutrophil count >= 1,500/mcL
15.0
Absolute neutrophil count >= 1,500/mcL
46.0
Absolute neutrophil count > 1000/mcL
36.0
Absolute neutrophil count >= 1,500/mcL
90.0
Absolute neutrophil count >= 1,500/mcL
45.0
Absolute neutrophil count >= 1,000/mcL
50.0
Absolute neutrophil count > 500/mcL
60.0
Within 2 weeks prior to initiation of study treatment: Absolute neutrophil count >= 1,500/mcL
70.0
Absolute neutrophil count >= 1,500/mcL
51.0
Absolute neutrophil count >= 1,500/mcL without the use of hematopoietic growth factors
48.0
Absolute neutrophil count >= 1,500/mcL
20.0
Absolute neutrophil count >= 1,500/mcL
60.0
Absolute neutrophil count >= 1,500/mcL
38.0
Absolute neutrophil count >= 1,500/mcL
70.0
Absolute neutrophil count >= 1,000/mcL
24.0
Absolute neutrophil count >= 1,500/mcL
35.0
Absolute neutrophil count >= 1,500/mcL
24.0
Absolute neutrophil count >= 1,000/mcL
28.0
Absolute neutrophil count >= 1,500/mcL
72.0
Absolute neutrophil count >= 1,000/mcL
40.0
Absolute neutrophil count >= 1,500/mcL
60.0
Absolute neutrophil count >= 1,500/mcL
180.0
Within 28 days prior to administration of study treatment: Absolute neutrophil count >= 1,500/mcL
90.0
Within 28 days prior to administration of therapy: Absolute neutrophil count >= 1,500/mcL
132.0
Absolute neutrophil count >= 1,500/mcL
40.0
Absolute neutrophil count >= 1,500/mcL
22.0
Absolute neutrophil count >= 1,500/mcL
70.0
Absolute neutrophil count >= 1,000/mcL
47.0
Absolute neutrophil count >= 1,500/mcL
35.0
Absolute neutrophil count >= 1,500/mcL
78.0
Leukocytes >= 3,000/mcL
40.0
Obtained within 30 days of registration: Leukocytes >= 3,000/mcL
24.0
Leukocytes >= 3,000/mm^3
110.0
Leukocytes >= 3,000/mcL
55.0
Leukocytes >= 3,000/mcL
42.0
Leukocytes >= 3,000/mcL
80.0
Leukocytes >= 3,000/mcL
70.0
Leukocytes >= 3,000/mcL
72.0
Leukocytes >= 3,000/mcL
12.0
Leukocytes >= 3,000/mcL
68.0
Leukocytes >= 3,000/mcL
130.0
Leukocytes >= 3,000/mcL
32.0
Leukocytes >= 3,000/mcL
100.0
Leukocytes >= 3,000/mcL
44.0
Leukocytes >= 3,000/mcL
57.0
Leukocytes >= 2,000/mcL
36.0
Leukocytes: >= 3,000/mm^3
56.0
Leukocytes >= 1,500/mcL
80.0
Leukocytes >= 3,000/mcL
135.0
Leukocytes >= 3,000/mcL
12.0
Leukocytes >= 3,000/mcL
209.0
Leukocytes >= 3,000/uL
35.0
Leukocytes >= 3,000/mcL
30.0
Leukocytes >= 3,000/mcL
30.0
Leukocytes >= 3,000/mm^3
126.0
Leukocytes >= 3,000/mcL
45.0
Leukocytes >= 2,000/uL
33.0
Leukocytes >= 3,000/mcL
126.0
Leukocytes >= 3,000/mcL
50.0
Leukocytes >= 3,000/mcL
46.0
Leukocytes >= 3,000/mcL
15.0
Leukocytes >= 3,000/mcL
46.0
Leukocytes >= 3,000/mcL
90.0
Leukocytes >= 3,000/mcL
45.0
Leukocytes >= 3,000/mcL
46.0
Leukocytes no lower limit
60.0
Within 2 weeks prior to initiation of study treatment: Leukocytes >= 3,000/mcL
70.0
Leukocytes >= 2,500/mcL
29.0
Leukocytes >= 3,000/mcL
51.0
Leukocytes >= 3,000/mcL
150.0
Leukocytes >= 3,000/mcL
48.0
Leukocytes >= 3,000/mcL
20.0
Leukocytes >= 3,000/mm^3
36.0
Leukocytes >= 3,000/mcL
38.0
Leukocytes >= 2,500/mcL
35.0
Leukocytes >= 3,000/mcL
72.0
Leukocytes >= 2,500/mcL
60.0
Within less than or equal to 14 days prior to registration: Leukocytes >= 3,000/mm^3
40.0
Leukocytes >= 3,000/mcL
40.0
Leukocytes >= 3,000/mcL
70.0
Leukocytes >= 3,000/mcL
47.0
Leukocytes >= 2,500/mcL
78.0
Granulocytes >= 1,500/ul
729.0
Absolute granulocytes >= 1500 cells/uL (1.5 x 10^9 L)
90.0
Granulocytes >= 1,500/ul
450.0
Granulocytes (ANC) >= 1,500/mcl
50.0
Peripheral absolute neutrophil count (ANC) >= 1000/mm^3
77.0
Peripheral absolute neutrophil count (ANC) >= 750/mm^3
484.0
* Peripheral absolute neutrophil count (ANC) >= 1000/mm^3
81.0
Peripheral absolute neutrophil count (ANC) >= 1000/mm^3
67.0
Peripheral absolute neutrophil count (ANC) >= 1000/mm^3
36.0
Absolute neutrophil count (ANC) >= 1,000/uL
400.0
Absolute neutrophil count (ANC) > 750/uL
253.0
Absolute neutrophil count (ANC) >= 1000/uL
100.0
Absolute neutrophil count (ANC) >= 1,500/uL
74.0
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L
132.0
Peripheral absolute neutrophil count (ANC) >= 1,000/uL
275.0
Peripheral absolute neutrophil count (ANC) >= 750/uL
74.0
Absolute neutrophil count >= 1,000/uL (unsupported), within 14 days of registration and within 7 days of the start of treatment
180.0
Absolute neutrophil count (ANC) >= 1000/uL
70.0
Absolute neutrophil count (ANC) >= 1500/uL
80.0
Absolute neutrophil count (ANC) >= 1,200/ul
97.0
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L
30.0
Absolute neutrophil count >= 1,500/uL
72.0
Absolute neutrophil count >= 1500/ul
104.0
Absolute neutrophil count (ANC) >= 1000/ul (unsupported)
52.0
Absolute neutrophil count (ANC) >= 1.0 x 10^9/L
97.0
Absolute neutrophil count (ANC) >= 1.2 x 10^9/L
40.0
Absolute neutrophil count (ANC) >= 1.2 x 10^9/L, within 2 weeks of the first dose of study treatment
18.0
Absolute neutrophil count (ANC) >= 1500/uL
92.0
Absolute neutrophil count (ANC) >= 1.2 x 10^9/L
68.0
Absolute neutrophil count (ANC) >= 1000/uL
28.0
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L
35.0
Absolute neutrophil count >= 1,500/uL
23.0
Absolute neutrophil count >= 1500/uL; Note: no transfusions are permitted 7 days prior to laboratory studies to determine eligibility
340.0
Absolute neutrophil count (ANC) >= 1,200/ul
280.0
Absolute neutrophil count (ANC) >= 1,500/uL, obtained within 4 weeks prior to randomization
300.0
Absolute neutrophil count (ANC) >= 1.2 x 10^9/L
18.0
Absolute neutrophil count (ANC) >= 1,500/ul
96.0
Absolute neutrophil count (ANC) >= 1,500/uL
400.0
Absolute neutrophil count >= 1,500/uL
58.0
Absolute neutrophil count >= 1000 cells/uL
110.0
INCLUSION CRITERIA FOR STRATUM C: Absolute neutrophil count >= 1000 cells/uL
110.0
Absolute neutrophil count >= 1,500/uL
35.0
Absolute neutrophil count (ANC) >= 1,500
23.0
Absolute neutrophil count > 1,500/uL
188.0
Absolute neutrophil count >= 1,500/uL
33.0
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L
36.0
Peripheral absolute neutrophil count (ANC) >= 750/uL
337.0
Absolute neutrophil count (ANC) > 1,500/uL
32.0
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L
64.0
Peripheral absolute neutrophil count (ANC) >= 1000/uL
45.0
Absolute neutrophil count (ANC) >= 1500/uL
40.0
Absolute lymphocyte count (ALC) >= 800/uL
40.0
Absolute neutrophil count (ANC) >= 1.2 x 10^9/L
68.0
Absolute neutrophil count (ANC) >= 1.5 x 10^9 /L
21.0
Absolute neutrophil count >= 1,500/uL
30.0
Absolute neutrophil count (ANC) >= 1,500/mcL
36.0
Absolute neutrophil count (ANC) >= 1,500/mcl
360.0
Absolute neutrophil count (ANC) >= 1,000 cells/mcL within 42 days prior to registration
155.0
Absolute neutrophil count (ANC) >= 1,500/mcl
52.0
Absolute neutrophil count (ANC) >= 1,500/mL within 28 days prior to registration
1900.0
Absolute neutrophil count (ANC) >= 1500/mcL (1.5 x 10^9/L) obtained within 2 weeks prior to registration
189.0
RE-REGISTRATION ELIGIBILITY CRITERIA (STEP 2): Absolute neutrophil count (ANC) >= 1.0 x 10^9/L
97.0
Absolute neutrophil count (ANC) greater than or equal to 1,500/mcl
540.0
Absolute neutrophil count (ANC) >= 1,200/mcL (subjects may be treated with hematopoietic growth factors to achieve or maintain this level)
130.0
Absolute neutrophil count (ANC) >= 1,500/mcl obtained within 28 days prior to sub-study registration
10000.0
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L measured within 28 days prior to randomization
1500.0
Absolute neutrophil count (ANC) >= 1,500/mcL
230.0
Absolute neutrophil count (ANC) >= 750/mcl within 28 days prior to registration
44.0
Obtained within 28 days prior to registration: Absolute neutrophil count (ANC) >= 1,500/mcL
223.0
Absolute neutrophil count (ANC) >= 1,500/mcL
150.0
Absolute neutrophil count (ANC) >= 1,000/mcL; must be obtained within 28 days prior to registration
180.0
Absolute neutrophil count (ANC) >= 1,500/mcL
46.0
Absolute neutrophil count (ANC) of >= 1,500/mL within 21 days prior to registration
333.0
Absolute neutrophil count (ANC) >= 1,500/mcL
150.0
Within 14 days prior to registration: Absolute neutrophil count (ANC) >= 1,500/mcL
143.0
CLINICAL/LABORATORY CRITERIA: Absolute neutrophil count (ANC) >= 1500/mcL; these results must be obtained within 28 days prior to registration
53.0
Absolute neutrophil count (ANC) greater than or equal to 1,500/mcl, within 14 days prior to registration; this ANC cannot have been induced by granulocyte colony stimulating factors
147.0
Absolute neutrophil count (ANC) >= 1,500/mcl
84.0
Obtained within 28 days prior to registration: Absolute neutrophil count (ANC) >= 1,500/mcl
77.0
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L within 14 days prior to registration.
186.0
Within 28 days prior to registration: ANC >= 1,000/mcL
707.0
Within 14 days prior to registration: Absolute neutrophil count (ANC) >= 1,500/mcl
488.0
Absolute neutrophil count (ANC) >= 1,500 microliter (mcL)
148.0
Within less than or equal to 14 days prior to registration: Absolute neutrophil count (ANC) >= 1.5 x 10^9/L
40.0
Absolute neutrophil count (ANC) >= 1,500 microliter (mcL), obtained within 28 days prior to step 2 registration
1000.0
Absolute neutrophil count (ANC) >= 1,500/mcL within 28 days prior to registration
64.0
Absolute neutrophil count (ANC) >= 1,500/mcL within 28 days prior to registration
150.0
Absolute neutrophil count (ANC) >= 1,500/mcL within 28 days prior to registration
94.0
Absolute neutrophil count (ANC) >= 1 x 10^9/L within 30 days of day 1 of study
27.0
White blood cell count >= 4000 cells/mm^3
285.0
White blood cell count (WBC) >= 4,000/ml
37.0
B-ALL patients must have an initial white blood cell count < 50,000/uL
9483.0
White blood cell (WBC) > 3.0
224.0
White blood cells (WBC) >= 3,000 cells/uL (3.0 x 10^9 L) or
90.0
Total white blood cells (WBC) >= 4.0 x 10^3/mcL within 28 days prior to registration
491.0
White blood cells (WBC) >= 3500/uL
92.0
White blood count >= 3,000/uL, obtained within 4 weeks prior to randomization
300.0
White blood count >= 3,000/uL
400.0
Patients with white blood cell (WBC) > 30,000 are not eligible to start therapy; however, it is permissible to use glucocorticoids and/or hydroxyurea to diminish peripheral WBC to less than 30,000 provided these agents are stopped at least 24 hours prior to the first dose of MLN0128 (TAK-228)
35.0
Total absolute phagocyte count (APC = [%neutrophils + %monocytes) x white blood cells [WBC]) is at least 1000/uL
44.0
White blood cell count (WBC) >= 2,000/mcL; must be obtained within 28 days prior to registration
180.0
White blood cell (WBC) >= 2000/uL
714.0
White blood cells >= 2000/uL, within 4 weeks of randomization
766.0
Within 28 days prior to administration of study treatment: White blood count (WBC) > 3 x 10^9/L
90.0
White blood cell count (WBC) >= 3 x 10^9/L
132.0
Absolute neutrophil count (ANC) >= 1,500/mm^3 obtained =< 21 days prior to registration
360.0
Absolute neutrophil count (ANC) >= 1,800 cells/mm^3
285.0
Absolute neutrophil count (ANC) >= 1,800 cells/mm^3
37.0
Absolute neutrophil count (ANC) >= 1,500/mm^3
545.0
Within 60 days prior to registration on study: Absolute neutrophil count (ANC) >= 1,500/mm^3
2580.0
Absolute neutrophil count (ANC) >= 1200/mm^3
48.0
Absolute neutrophil count (ANC) >= 1,500/mm^3
1120.0
Absolute neutrophil count (ANC) >= 1,200 cells/mm^3, within 21 days prior to study entry
143.0
Within 14 days prior to registration: Absolute neutrophil count (ANC) >= 1,000 cells/mm^3 without growth factor support
130.0
Absolute neutrophil count (ANC) >= 1,500 cells/mm^3; obtained within 14 days prior to study entry
368.0
STEP I: Absolute neutrophil count >= 1000 cells/mm^3 (obtained within 28 days prior to randomization)
1080.0
Obtained =< 7 days prior to registration: Absolute neutrophil count (ANC) >= 1500/mm^3
102.0
Absolute neutrophil count (ANC) >= 1,800 cells/mm^3
252.0
Absolute neutrophil count (ANC) >= 1,000 cells/mm^3
234.0
Absolute neutrophil count (ANC) > 1,000/mm^3
2060.0
Absolute neutrophil count (ANC) >= 1,500 cells/mm^3 obtained within 30 days prior to registration
330.0
Absolute neutrophil count (ANC) > 750 cells/mm^3 within 90 days prior to randomization
150.0
Absolute neutrophil count (ANC) >= 1500 cells/mm^3 within 14 days prior to study registration
440.0
Absolute neutrophil count (ANC) >= 1,500/mm^3
34.0
Absolute neutrophil count (ANC) >= 1,500 cells/mm^3, within 21 days prior to registration
924.0
Absolute neutrophil count (ANC) >= 1,500/mm^3
20.0
Absolute neutrophil count (ANC) >= 500 cells/mm^3
84.0
Absolute neutrophil count (ANC) >= 1,500 cells/m^3
182.0
Absolute neutrophil count (ANC) >= 1,000/mm^3
30.0
Absolute neutrophil count (ANC) >= 1,500 cells/mm^3
606.0
Absolute neutrophil count (ANC) >= 1500/mm^3
NONE
Absolute neutrophil count (ANC) >= 1,500/mm^3
420.0
Absolute neutrophil count (ANC) >= 500 cells/mm^3
360.0
Absolute neutrophil count (ANC) > 1500 mm^3, must be obtained within 8 weeks prior to screening for protocol therapy
562.0
ELIGIBILITY CRITERIA FOR RANDOMIZATION (STEP 1): Absolute neutrophil count (ANC) > 1500 mm^3
562.0
Absolute neutrophil count (ANC) >= 1500/mm^3
60.0
Within 6 weeks prior to randomization: Absolute neutrophil count (ANC) must be >= 1200/mm^3
990.0
Absolute neutrophil count (ANC) >= 1,500/mm^3
195.0
Re-registration: ANC >= 1,500/mm^3
195.0
Within 14 days of registration: Absolute neutrophil count (ANC) >= 1,500/mm^3
110.0
Absolute neutrophil count (ANC) >= 1,500/mm^3
69.0
Absolute neutrophil count (ANC) >= 1,500/mm^3
130.0
Absolute neutrophil count (ANC) >= 1,500/mm^3
45.0
Absolute neutrophil count (ANC) >= 1,500/mm^3
137.0
Absolute neutrophil count (ANC) must be >= 1200/mm^3 within 28 days before randomization
348.0
Absolute neutrophil count (ANC) >= 1,500/mm^3
124.0
Absolute neutrophil count (ANC): >= 1,500 /mm^3
56.0
Absolute neutrophil count (ANC) >= 1500 mm^3
700.0
Absolute neutrophil count (ANC) >= 750/mm^3
324.0
Absolute neutrophil count (ANC) >= 1,000 cells/mm^3
186.0
Absolute neutrophil count (ANC) >= 1,500 cells/mm^3
120.0